OTTAWA, Feb. 27, 2018 /CNW/ - Joule, a Canadian Medical Association company, is pleased to see funds in the 2018 Federalbudget dedicated to science and innovation. We agree with the government that support to the next generation of researchers has the potential to yield meaningful change and innovation.
As an organization dedicated to physician-led innovation,
Finding opportunities with all levels of government to support physician-led innovation will continue to be a Joule priority. In doing so, we know that we can help provide solutions to many of the health-related issues that Canadians face on a daily basis and drive health system transformation.
Lindee DavidJoule CEO
Joule is the Canadian Medical Association's (CMA's) newest subsidiary designed to assist physicians in the pursuit of clinical excellence. Joule does this explicitly through the support of physician-led innovation, and by inspiring physician-adoption of knowledge products and innovative technologies and services. Our purpose is to accelerate physician-led innovation and adoption of advances that deliver excellence in health and patient care. Our mission is to help physicians be at their best.
Subscribe to our Free Newsletters!
Alström syndrome, a rare genetic disorder due to ALMS1 mutations, occurs in the first year of ...
Sodium zirconium cyclosilicate was approved by FDA recently to use as an oral suspension for ...
Encephalocele is a birth defect where a sac like protrusion of brain and covering membranes occurs ...View All